TScan Therapeutics Inc. (TCRX:NASDAQ) soared at $4.85, a gain of 42.6%. On Wed, May 10, 2023, TCRX:NASDAQ touched a New 2-Week High of $4.85. The stock appeared on our News Catalysts scanner on Wed, May 10, 2023 at 07:41 AM in the 'INVESTOR UPDATE' category. From Wed, Apr 26, 2023, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Tue, May 09, 2023 at $6.03 with a volume of 49M+.
About TScan Therapeutics Inc. (TCRX:NASDAQ)
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer.
Top 10 Gainers:
- CTI BioPharma Corp. (CTIC:NASDAQ), 85.27%
- iMedia Brands, Inc. (IMBI:NASDAQ), 82.5%
- Harbor Custom Development Inc. (HCDI:NASDAQ), 80.08%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 75.61%
- Inspirato Inc Cl A (ISPO:NASDAQ), 47.63%
- Microvast Holdings Inc. (MVST:NASDAQ), 42.75%
- TScan Therapeutics Inc. (TCRX:NASDAQ), 42.65%
- Xometry Inc. (XMTR:NASDAQ), 39.91%
- Benson Hill Inc. (BHIL:NYSE), 38.21%
- Compass Inc. Class A (COMP:NYSE), 35%